Navigation Links
The CLS Hip Stem

ProductsThe CLS Hip Stem
Company Zimmer, Inc.
Item The CLS Hip Stem
Features The CLS is a grit-blasted, titanium, cementless stem, patented, tapered fins are designed to optimize proximal fixation in cancellous bone while a tapered, rectangular, cross-section provides excellent rotational stability.
Description The standard of proximal press-fit design. The CLS hip is a straight stem design that is available in 13 sizes in two different neck angles, 135 and 145, to accommodate a wide variety of patient anatomies.
Info Zimmer, Inc.
Customer Service: (800) 613-6131
Web site: http://www.zimmer.com

Related medicine products :

1. The Natural-Hip Family - Revision/Trauma Nonporous CoCr
2. The Natural-Hip Family - Revision/Trauma CoCr Revision
3. The Natural-Hip Family - Revision/Trauma Calcar
4. The Natural-Hip Family - High Demand Porous (collared)
5. The Natural-Hip Family - High Demand Porous (short neck)
6. The Natural-Hip Family - Specialty Porous Collared HA
7. The Natural-Hip Family - Specialty Porous collarless HA
8. The Natural-Hip Family - Medium Demand Premier
9. The Natural-Hip Family - Low Demand (LD)
10. Surgicel Absorbable Hemostat Family
11. The APR Hip Family - CoCr Cemented
TAG: The CLS Hip Stem
The ENDOPATH EZ45 No-Knife Endoscopic Linear Stapler has application in multiple open or other minimally invasive surgical procedures for transection and resection, and can be used with staple line o
Improved Access in Open Procedures with Compact Endoscopic Linear Cutters., ,Staplers may be reloaded seven times for a total of eight firings. Different cartridges of the same size can be interchan
...able clip applier is designed for use with the END...f which contains eight (8) titanium clips., ,...is approximately 12.8" (32.5 cm). The clip applier...ppropriately sized Auto Suture trocar sleeve or la...
ACUCLIP Endoscopic Right-Angle Multiple Clip Applier, 10 mm Shaft Diameter with 20, 8 mm Titanium Clips
Medicine Products:
(Date:12/3/2008).../ -- Memory Pharmaceuticals,Corp. (Nasdaq: MEMY...Company,received notification from the NASDAQ Lis...Panel has determined to delist the Company,s secur...he Company was also notified today that,the NASDA...Council") has,called for review the Panel,s Decem...
(Date:12/3/2008)... Belmont(R) Rapid Infuser, a,medical device used ...ounded,soldiers, civilians, and enemy combatants ...e of an Omaha, NE Police Officer. , The off...ne of the bullets,hit him in the abdomen and trav... "Injury to this area is often lethal... when he...
(Date:12/3/2008)...hinner imported from China , , WEDNESDAY... deadly contamination of the blood thinner heparin...e chemical that was added to batches of the drug i..., The crisis, which began last November, resulted ...in the United States. The Chinese heparin, contami...
(Date:12/3/2008)...Call/ -- As previously announced, HLTH Corporation...ebMD Health Corp. (Nasdaq: WBMD ), will be holdi... at 9:30 a.m. Eastern Time on Wednesday, December ... meetings will be available over the Internet. To ...tors can go to www.hlth.com (in the Investor Rel...
Breaking Medicine News(10 mins):Health News:Memory Pharmaceuticals Receives NASDAQ Decisions 2Health News:Memory Pharmaceuticals Receives NASDAQ Decisions 3Health News:Belmont(R) Rapid Infuser Helps Save Officer's Life 2Health News:Report Confirms Source of Contaminated Heparin 2Health News:Report Confirms Source of Contaminated Heparin 3Health News:HLTH Corporation and WebMD to Webcast Annual Meetings of Stockholders 2
...titute of Standards and Technology (NIST) research...duce a number of complex surfaces, which vary in a...w technique is so flexible that it can be applied ...m developing better paints to exploring the bondin...
...long-term research a geographer from Guangdong Pro... clues to the pattern of global climate change. //...ences has opined that rising temperatures globally...eenhouse effect but in fact was a part of the cycl...
...appearing in the American Journal of Clinical Nutr...ur ancestors is responsible for the overweight/obe... In a study of men who chewed betel nut, it was fo...r sons and grandsons. Barbara Boucher, of the Uni...
... on the manner of T-cells enabling immunity and fu...us similar to AIDS will go a long way in measuring...ists during clinical trials //. Led by researcher...ter (BIDMC) and the Vaccine Research Center (VRC) ...
Other Medicine News:Health News:New Technique For Science Experiments 2Health News:Research on AIDS vaccine a wealth of information 2Health News:Research on AIDS vaccine a wealth of information 3
(Date:12/1/2008)...ewswire-FirstCall/ -- Vical Incorporated (Nasdaq: ...lion milestone payment from Merck & Co., Inc. ...linical trial of an investigational plasmid DNA (p...d on Vical,s DNA gene delivery technology and enco.... hTERT is the subject of separate license agreeme...
(Date:11/28/2008)... November 28 German biotech compan...ecialized HIV monitoring and,AIDS patient follow-...es. In,the year 2008, 2.5 million patient tests h...highly affordable "CyFlow" system, supporting alre...DS. Due to introduction of the,Partec innovation,...
(Date:11/26/2008)... 26 Children whose eyes...ntly increased risk of developing mental illness b...o Clinic study published this month in Pediatrics ...Pediatrics. , , The retrospective study exa...abismus (misaligned eyes) and compared them with r...
(Date:11/25/2008)...improve recovery , , Audio and Web Video Re...he Mayo Clinic News Blog. Please see the bottom of...ER, Minn., Nov. 25 A Ma...s don,t think they,re having a stroke -- and as a ...ition worsens. The findings appear in the current ...
Breaking Medicine Technology:Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008 2Eye Divergence in Children Triples Risk of Mental Illness 2Do You Know You're Having a Stroke? 2Do You Know You're Having a Stroke? 3CVS Caremark Reports Record Second Quarter Revenues Operating Profit and Earnings 24716 1CVS Caremark Reports Record Second Quarter Revenues Operating Profit and Earnings 24716 2CVS Caremark Reports Record Second Quarter Revenues Operating Profit and Earnings 24716 3CVS Caremark Reports Record Second Quarter Revenues Operating Profit and Earnings 24716 4CVS Caremark Reports Record Second Quarter Revenues Operating Profit and Earnings 24716 5CVS Caremark Reports Record Second Quarter Revenues Operating Profit and Earnings 24716 6CVS Caremark Reports Record Second Quarter Revenues Operating Profit and Earnings 24716 7CVS Caremark Reports Record Second Quarter Revenues Operating Profit and Earnings 24716 8CVS Caremark Reports Record Second Quarter Revenues Operating Profit and Earnings 24716 9CVS Caremark Reports Record Second Quarter Revenues Operating Profit and Earnings 24716 10CVS Caremark Reports Record Second Quarter Revenues Operating Profit and Earnings 24716 11CVS Caremark Reports Record Second Quarter Revenues Operating Profit and Earnings 24716 12CVS Caremark Reports Record Second Quarter Revenues Operating Profit and Earnings 24716 13CVS Caremark Reports Record Second Quarter Revenues Operating Profit and Earnings 24716 14CVS Caremark Reports Record Second Quarter Revenues Operating Profit and Earnings 24716 15CVS Caremark Reports Record Second Quarter Revenues Operating Profit and Earnings 24716 16CVS Caremark Reports Record Second Quarter Revenues Operating Profit and Earnings 24716 17CVS Caremark Reports Record Second Quarter Revenues Operating Profit and Earnings 24716 18CVS Caremark Reports Record Second Quarter Revenues Operating Profit and Earnings 24716 19CVS Caremark Reports Record Second Quarter Revenues Operating Profit and Earnings 24716 20CVS Caremark Reports Record Second Quarter Revenues Operating Profit and Earnings 24716 21CVS Caremark Reports Record Second Quarter Revenues Operating Profit and Earnings 24716 22The Quigley Corporation Reports Second Quarter 2008 Results 3A Continues Investment in Pharmaceutical R 26D Future 6843 1The Quigley Corporation Reports Second Quarter 2008 Results 3A Continues Investment in Pharmaceutical R 26D Future 6843 2The Quigley Corporation Reports Second Quarter 2008 Results 3A Continues Investment in Pharmaceutical R 26D Future 6843 3The Quigley Corporation Reports Second Quarter 2008 Results 3A Continues Investment in Pharmaceutical R 26D Future 6843 4The Quigley Corporation Reports Second Quarter 2008 Results 3A Continues Investment in Pharmaceutical R 26D Future 6843 5The Quigley Corporation Reports Second Quarter 2008 Results 3A Continues Investment in Pharmaceutical R 26D Future 6843 6New Website Helps Doctors and Dentists Locate Disability Insurance 24714 1New Website Helps Doctors and Dentists Locate Disability Insurance 24714 2New Website Helps Doctors and Dentists Locate Disability Insurance 24714 3Healthcare Leaders Focus on Patient Centered Care at Annual Planetree Conference 24709 1Healthcare Leaders Focus on Patient Centered Care at Annual Planetree Conference 24709 2Healthcare Leaders Focus on Patient Centered Care at Annual Planetree Conference 24709 3
...srael--(BUSINESS WIRE)--Jun 14, 2007 - Can-Fite,Bi...d on the Tel,Aviv Stock Exchange Exchange, proceed...is is in addition to CF101, which is currently,in ... phases. This,weekend Can-Fite will present at the...d in vivo study results showing effective,anti-inf...
....--(BUSINESS WIRE)--Jun 14, 2007 - CombinatoRx,In...entation of,additional data related to its immuno-...39, at the European League Against,Rheumatism (EUL...13-16, 2007 in Barcelona, Spain., CRx-102 , In a p...rocyte,Inflammatory Mediators by CRx-102, a Novel ...
Other Medicine Technology:Can-Fite Proceeds with Development of Third Drug; Progress in,Development of CF502 Will Be Presented at the Annual European,Congress of Rheumatology 2Additional Data on CombinatoRx Drug Candidates CRx-102 and CRx-139,Presented at EULAR 2Additional Data on CombinatoRx Drug Candidates CRx-102 and CRx-139,Presented at EULAR 3Additional Data on CombinatoRx Drug Candidates CRx-102 and CRx-139,Presented at EULAR 4